• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Osong Public Health Res Perspect . Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020

tetano

Editor, Senior Moderator
Osong Public Health Res Perspect


. 2021 Feb;12(1):37-43.
doi: 10.24171/j.phrp.2021.12.1.06.
Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020


Ae Kyung Park[SUP] 1 [/SUP], Il-Hwan Kim[SUP] 1 [/SUP], Junyoung Kim[SUP] 2 [/SUP], Jeong-Min Kim[SUP] 1 [/SUP], Heui Man Kim[SUP] 1 [/SUP], Chae Young Lee[SUP] 1 [/SUP], Myung-Guk Han[SUP] 3 [/SUP], Gi-Eun Rhie[SUP] 4 [/SUP], Donghyok Kwon[SUP] 5 [/SUP], Jeong-Gu Nam[SUP] 6 [/SUP], Young-Joon Park[SUP] 7 [/SUP], Jin Gwack[SUP] 7 [/SUP], Nam-Joo Lee[SUP] 1 [/SUP], SangHee Woo[SUP] 1 [/SUP], Jin Sun No[SUP] 4 [/SUP], Jaehee Lee[SUP] 1 [/SUP], Jeemin Ha[SUP] 8 [/SUP], JeeEun Rhee[SUP] 1 [/SUP], Cheon-Kwon Yoo[SUP] 9 [/SUP], Eun-Jin Kim[SUP] 1 [/SUP]



Affiliations

Abstract

Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22[SUP]nd[/SUP], 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25[SUP]th[/SUP], 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.

Keywords: Republic of Korea; SARS-CoV-2; whole-genome sequencing.
 
Back
Top Bottom